Doctor profile · Federal record
Dr. SHRINIVAS KAMBALI, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · SAGINAW, MI
- NPI 1104056290
- Accepts Medicare
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1015 S WASHINGTON AVE, SUITE D
SAGINAW, MI 486012556
(989) 907-7636
fax (989) 907-7584
Credentials & registration
- NPI registered
- July 2009 — 17 yrs on file
- Profile last updated
- April 6, 2021
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Michigan #4301092283
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104056290. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,361
Distinct HCPCS
10
Medicare allowed
$105,186
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 207 | 95 | $73 | |
99291 |
Critical care, first 30-74 minutes | 153 | 65 | $203 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 150 | 149 | $10 | |
94726 |
Test to determine lung volumes using sensors | 150 | 149 | $11 | |
94729 |
Test to examine how well the lungs exchange gases | 150 | 149 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 144 | 98 | $122 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 135 | 76 | $111 | |
94618 |
Test for exercise-induced lung stress | 82 | 82 | $21 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 63 | 53 | $86 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 34 | 34 | $155 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 68. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$3,131
Transactions
36
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | 5 | $2,310.46 | |
| GlaxoSmithKline, LLC. | 22 | $363.43 | |
| AstraZeneca Pharmaceuticals LP | 7 | $349.16 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $85.35 | |
| GENZYME CORPORATION | 1 | $22.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,563
Patients
540
Total drug cost
$668,398
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 416 | 105 | $435,006 |
| Prednisone | Generic | 233 | 101 | $1,041 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 215 | 105 | $8,871 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 125 | 36 | $62,457 |
| Montelukast Sodium | Generic | 106 | 33 | $1,688 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 84 | 26 | $38,888 |
| Azithromycin | Generic | 72 | 25 | $675 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 57 | 32 | $4,653 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 47 | 17 | $41,783 |
| Roflumilast | Generic | 43 | 13 | $14,447 |